Prediction of Autopsy Verified Neuropathological Change of Alzheimer's Disease Using Machine Learning and MRI

Alzheimer’s Disease

Prediction of Alzheimer's disease dementia with MRI beyond the short-term: Implications for the design of predictive models

Neuroimage Clin.

Moscoso A, Silva-Rodríguez J, Aldrey JM, Cortés J, Fernández-Ferreiro A, Gómez-Lado N, Ruibal Á, Aguiar P, Alzheimer's Disease Neuroimaging Initiative.

doi: 10.1016/j.nicl.2019.101837.

Aging and Cognitive FunctionsDementia

Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease

Brain.

Vogel JW, Vachon-Presseau E, Pichet Binette A, Tam A, Orban P, La Joie R, Savard M, Picard C, Poirier J, Bellec P, Breitner JCS, Villeneuve S; Alzheimer’s Disease Neuroimaging Initiative* and the PREVENT-AD Research Group

doi: 10.1093/brain/awy093.

Aging and Cognitive FunctionsAlzheimer’s Disease

Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain <sup>1</sup>H-MRS and volumetric changes: A two- year retrospective follow-up study

Neuroimage Clin.

Mitolo M, Stanzani-Maserati M, Capellari S, Testa C, Rucci P, Poda R, Oppi F, Gallassi R, Sambati L, Rizzo G, Parchi P, Evangelisti S, Talozzi L, Tonon C, Lodi R, Liguori R

doi: 10.1016/j.nicl.2019.101843.

Aging and Cognitive FunctionsAlzheimer’s Disease

An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease

Neurology.

Brickman AM, Tosto G, Gutierrez J, Andrews H, Gu Y, Narkhede A, Rizvi B, Guzman V, Manly JJ, Vonsattel JP, Schupf N, Mayeux R

doi: 10.1212/

Aging and Cognitive FunctionsDementia

A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information

J Alzheimers Dis.

Steenland K, Zhao L, John SE, Goldstein FC, Levey A, Alvaro A; Alzheimer’s Disease Neuroimaging Initiative

doi: 10.3233/JAD-170769.

Alzheimer’s Disease

Predicting progression to Alzheimer's disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests

J Neurol.

De Simone MS, Perri R, Fadda L, Caltagirone C, Carlesimo GA

doi: 10.1007/s00415-018-9108-0.

Alzheimer’s Disease

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Lancet Neurol.

Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, Chamoun M, Savard M, Kang MS, Therriault J, Schöll M, Massarweh G, Soucy JP, Höglund K, Brinkmalm G, Mattsson N, Palmqvist S, Gauthier S, Stomrud E, Zetterberg H, Hansson O, Rosa-Neto P, Blennow K

doi: 10.

Dementia

Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia

Alzheimers Dement.

Slot RER, Sikkes SAM, Berkhof J, Brodaty H, Buckley R, Cavedo E, Dardiotis E, Guillo-Benarous F, Hampel H, Kochan NA, Lista S, Luck T, Maruff P, Molinuevo JL, Kornhuber J, Reisberg B, Riedel-Heller SG, Risacher SL, Roehr S, Sachdev PS, Scarmeas N, Scheltens P, Shulman MB, Saykin AJ, Verfaillie SCJ, Visser PJ, Vos SJB, Wagner M, Wolfsgruber S, Jessen F; Alzheimer's Disease Neuroimaging Initiative, the DESCRIPA working group, the INSIGHT-preAD study group, on behalf of the SCD-I working group, van der Flier WM

doi: 10.1016/j.jalz.2018.10.003.

Dementia

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study

Lancet Neurol.

Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Marcus DS, Fagan AM, Jack CR Jr, Hornbeck RC, Paumier KL, Ances BM, Berman SB, Brickman AM, Cash DM, Chhatwal JP, Correia S, Förster S, Fox NC, Graff-Radford NR, la Fougère C, Levin J, Masters CL, Rossor MN, Salloway S, Saykin AJ, Schofield PR, Thompson PM, Weiner MM, Holtzman DM, Raichle ME, Morris JC, Bateman RJ, Benzinger TLS

doi: 10.1016/

Related content

Prediction of Alzheimer's disease dementia with MRI beyond the short-term: Implications for the design of predictive models

Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease

Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain <sup>1</sup>H-MRS and volumetric changes: A two- year retrospective follow-up study

An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease

A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information

Predicting progression to Alzheimer's disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study